Navigation Links
Robert Farrell Joins Bionovo's Board of Directors
Date:1/5/2012

EMERYVILLE, Calif., Jan. 5, 2012 /PRNewswire/ -- Bionovo Inc. (NASDAQ: BNVI) announced today the appointment of Robert E. Farrell, J.D., to the Company's Board of Directors.  Mr. Farrell will also serve as an independent director and member of the Company's Audit and Compensation committees. Mr. Farrell has more than 20 years of financial management experience in the pharmaceutical and biotech industries.

(Logo: http://photos.prnewswire.com/prnh/20111110/SF04662LOGO)

"We are very excited to add Mr. Farrell to our Board of Directors," stated Isaac Cohen, O.M.D., Bionovo's Chairman and Chief Executive Officer. "Bob has extensive experience with public markets, financial regulatory issues and with the structuring of corporate partnerships in the pharmaceutical and life science industries.  We believe Mr. Farrell's background in these areas will prove valuable to Bionovo's current efforts, and we are quite excited to have access to his expertise."

From 1996-2009, Mr. Farrell held the positions of Executive Vice President and CFO of Titan Pharmaceuticals, Inc. and was appointed President and CEO of Titan in December 2008, a position that he held through 2009.  Prior to Titan Pharmaceuticals, from 1991-1996, Mr. Farrell served as Corporate Group Vice President and CFO of Fresenius USA, a pharmaceutical manufacturing and medical device company focused on the treatment of end-stage renal disease.

Mr. Farrell holds an undergraduate degree from the University of Notre Dame and received his J.D. degree from the University of California.

"I believe that Menerba, and Bionovo's pipeline of other drugs and innovative technologies, will provide safer treatments for unmet needs in the areas of women's health and cancer. I look forward to working with the Company as it advances
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
2. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
3. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
4. Robert Cantu Appointed Vice President of Pierpoint International
5. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
6. Danaher to Present at Robert W. Baird Industrial Conference
7. Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
8. CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
9. Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development
10. Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition
11. Healthplace America Engages Robert A. Yungk to Provide Services as Chief Strategy Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014  Decision Resources Group finds that the ... will grow moderately through 2023 as the aging population, ... of dental biomaterials all spur procedure volumes. Growth will ... China and India ... within reach for a larger proportion of the population. ...
(Date:12/17/2014)... The Activated Carbon Manufacturing ... why IBISWorld updated its original industry research report. ... an intensified focus on environmental policy. Over the five ... for power plants and a range of other industrial ... Analyst Sarah Kahn, “a range of downstream industrial sectors ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
... 3 Trials on Track for Initiation Later This Year ... at 8:30 a.m. Eastern Time -, SAN DIEGO, ... announced today that an independent Echocardiographic,Data Safety Monitoring Board ... ongoing pivotal Phase 3 trial, BLOOM (Behavioral modification and,Lorcaserin ...
... 11 GeneGo, Inc. and the Cystic,Fibrosis Foundation ... for the integration and analysis of cystic fibrosis ... and,algorithms for understanding the complex interconnected pathways that ... this collaboration will better help us to understand ...
... in October At U.S. Psychiatric Congress, PARSIPPANY, ... that it has acquired the unique Bipolar Disorder,treatment, ... EQUETRO(R) is a treatment for the acute manic ... condition where patients experience,extended periods of exaggerated highs ...
Cached Biology Technology:Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 3Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 4Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 5Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 6GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis 2GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis 3Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R) 2
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014 /PRNewswire/ ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ... Adding functional endpoints to toxicology studies ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... Inc. and AmberGen, Inc. announced today that ... whereby AmberGen will provide its proprietary photocleavable ... SomaLogic,s SOMAscanTM technology platform. The ... high-throughput proteomic quantitation platform is achieving sufficient ...
... of rainbow trout -- one in Alaska, the other in ... implications for fisheries conservation and management, an eight-member research team ... of development that has allowed these different salmomid subspecies to ... researchers, in a paper put online ahead of publication in ...
... a plant pathologist. His most recent research project revolved ... analyzed a special class of genes that encode cell ... these enzymes when attacking a plant. But while investigating ... came in different sizes in different individuals. To ...
Cached Biology News:Genetic buzzer-beater genes may save fish 2Genetic buzzer-beater genes may save fish 3Shedding light on the 'dark matter' of the genome 2Shedding light on the 'dark matter' of the genome 3Shedding light on the 'dark matter' of the genome 4
8 different frozen tissues are mounted on positively charged glass slides...
... The MEGAscript RNAi Kit ... of large mass amounts of ... in non-mammalian systems. The MEGAscript ... Ambions patented high-yield transcription technol-ogy ...
...
... VSO LF (Low Flow) offers the same benefits ... for applications where control is critical or flow ... valve automates the flow of gas in proportion ... DC current or pulse width modulation; closed loop ...
Biology Products: